Showing results (751-760 of 895) with videos related to
Sort By:
Pageof 90
Drugs in R&D|October 31, 2003
Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administrationRisto Huupponen, Outi Paija, Markku Salonen, et al.Drugs in R&D|October 31, 2003
Cinacalcet: AMG 073, Calcimimetics--Amgen/NPS Pharmaceuticals, KRN 1493, NPS 1493Drugs in R&D|October 31, 2003
Doripenem: S 4661Drugs in R&D|October 31, 2003
Petasites--Zeller: ZE 339Drugs in R&D|May 22, 2003
Effects of levocarnitine on mitochondrial antioxidant systems and oxidative stress in aged ratsSundaram Kumaran, Balasubramanium Deepak, Balasubramanium Naveen, et al.Drugs in R&D|May 22, 2003
Oxymorphone--Endo/Penwest: EN 3202, EN 3203Drugs in R&D|April 30, 2003
Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary reportStanislaw R Burzynski, Robert I Lewy, Robert A Weaver, et al.Drugs in R&D|October 18, 2019
The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT StudyAndreas Muehler, Hella Kohlhof, Manfred Groeppel, et al.Drugs in R&D|August 29, 2018
New Insights on the Pharmacokinetics of Ulifloxacin After Administration of Prulifloxacin in Patients with Mild, Moderate and Severe Renal ImpairmentValeria Tellone, Paola Coppola, Marco Ammendola, et al.Drugs in R&D|May 19, 2017
Pharmacokinetic Bioequivalence Studies of an Extended-Release Oxycodone Hydrochloride Tablet in Healthy Japanese Subjects Under Fasting and Fed Conditions Without an Opioid AntagonistKaoru Toyama, Hidetoshi Furuie, Kana Kuroda, et al.Pageof 90